PPARG and melanoma: In contrast to the anti-tumorigenic function of PPARγ in DCs proposed by many studies, Zhao and colleagues identified a paracrine Wnt5a-β-catenin-PPAR-γ signaling pathway driving FAO in DCs by which melanomas escape from immunotherapies.